C12Y 301/21002
Deoxyribonuclease iv
Official title: Deoxyribonuclease IV (phage-T(4)-induced)(3.1.21.2)
C12Y301/21002 (Deoxyribonuclease iv) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 6
- Assignees
- 5
- Inventors
- 13
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Fusion protein construct24 Sep 2024US 12,098,215 B2Northwestern University
- Methods for true isothermal strand displacement amplification13 Apr 2021US 10,975,423 B2Elitechgroup B.V.
- Therapeutic for treating clostridium difficile infection7 Aug 2018US 10,039,812 B2London School of Hygiene and Tropical Medicine
- Therapeutic for treating Clostridium difficile infection8 Dec 2015US 9,205,133 B2London School of Hygiene and Tropical Medicine
- Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease12 Apr 1994US 5,302,389 ABoard of Regents, The University of Texas System
- Fusion Protein Construct20 Feb 2025US 2025/0059301 A1Northwestern University
- Methods for true isothermal strand displacement amplification6 Feb 2020US 2020/0040387 A1Elitechgroup B.V.
- Fusion Protein Construct30 May 2019US 2019/0161556 A1Northwestern University
- Method for Reducing Sequencing Errors Caused by DNA Fragmentation22 Feb 2018US 2018/0051341 A1New England Biolabs, Inc.
- Therapeutic for treating clostridium difficile infection3 Mar 2016US 2016/0058846 A1London School of Hygiene and Tropical Medicine
Most cited
By later US patents
- Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease21US 5,302,389 ABoard of Regents, The University of Texas System · 1994
- Therapeutic for treating Clostridium difficile infection15US 9,205,133 B2London School of Hygiene and Tropical Medicine · 2015
- Therapeutic for treating clostridium difficile infection1US 10,039,812 B2London School of Hygiene and Tropical Medicine · 2018